Back to search
FDAFDA · Food and drugs·Recall number D-0714-2018

Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-014-10

Published May 2, 2018 · Recall initiated: April 23, 2018

Summary

FDA records drug Class III recall D-0714-2018, published May 2, 2018 and initiated April 23, 2018. Recalling firm: Mckesson Packaging Services; Status: Terminated; Reported quantity: 4266 cartons; Lot: Lot #: 0115086, Exp. 12/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications. High dissolution results were obtained during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Packaging Services
Distributor
Nationwide with the US
Lot
Lot #: 0115086, Exp. 12/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-014-10 recalled?

Yes. FDA published recall D-0714-2018 on May 2, 2018. Reported hazard: Failed Dissolution Specifications. High dissolution results were obtained during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter